BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29068868)

  • 21. Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
    Boddu P; Garcia-Manero G; Ravandi F; Borthakur G; Jabbour E; DiNardo C; Jain N; Daver N; Pemmaraju N; Anderlini P; Parmar S; Kc D; Akosile M; Pierce SA; Champlin R; Cortes J; Kantarjian H; Kadia T
    Am J Hematol; 2017 Dec; 92(12):1295-1302. PubMed ID: 28850699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia.
    Kosaka Y; Yagasaki H; Sano K; Kobayashi R; Ayukawa H; Kaneko T; Yabe H; Tsuchida M; Mugishima H; Ohara A; Morimoto A; Otsuka Y; Ohga S; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
    Blood; 2008 Feb; 111(3):1054-9. PubMed ID: 17989314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between Serum G-CSF Level and Immune Function in Children with Aplastic Anemia].
    Ren R; Han J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):819-823. PubMed ID: 35680811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
    Fang JP; Xu HG; Huang SL; Chen C; Huang K
    Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunosuppressive therapy for adult aplastic anemia in a single institution study].
    Iki S; Usuki K; Iijima K; Urabe A
    Rinsho Ketsueki; 2005 Apr; 46(4):261-8. PubMed ID: 16444958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
    Zheng Y; Liu Y; Chu Y
    Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamer-based proteomics of serum and plasma in acquired aplastic anemia.
    Giudice V; Biancotto A; Wu Z; Cheung F; Candia J; Fantoni G; Kajigaya S; Rios O; Townsley D; Feng X; Young NS
    Exp Hematol; 2018 Dec; 68():38-50. PubMed ID: 30312735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of immunosuppressive therapy for childhood aplastic anemia and its predictive factors].
    Zhao FY; Xu XJ; Song H; Yang SL; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):567-70. PubMed ID: 22898273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increasing peripheral blood neutrophils after G-CSF treatment is a predictor of early response to immunosuppressive therapy in severe aplastic anemia].
    Wu Z; Yang W; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Zhao X; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):974-9. PubMed ID: 25417872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of pediatric acquired aplastic anemia: a developing world experience.
    Ramzan M; Yadav SP; Zafar MS; Dinand V; Sachdeva A
    Pediatr Hematol Oncol; 2014 Feb; 31(1):29-38. PubMed ID: 23802844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia.
    Deyell RJ; Shereck EB; Milner RA; Schultz KR
    Pediatr Hematol Oncol; 2011 Sep; 28(6):469-78. PubMed ID: 21707222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Front-line immunosuppressive treatment of acquired aplastic anemia.
    Dufour C; Svahn J; Bacigalupo A;
    Bone Marrow Transplant; 2013 Feb; 48(2):174-7. PubMed ID: 23165493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Suzuki K; Muramatsu H; Okuno Y; Narita A; Hama A; Takahashi Y; Yoshida M; Horikoshi Y; Watanabe K; Kudo K; Kojima S
    Int J Hematol; 2016 Jul; 104(1):130-3. PubMed ID: 27107757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment outcomes of 125 children with aplastic anemia].
    Luo CJ; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Dong L; Luo CY; Ye QD; Zhou M; Gu LJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):531-5. PubMed ID: 21122332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.